Multispecific drugs herald a new era of biopharmaceutical innovation DOI
Raymond J. Deshaies

Nature, Journal Year: 2020, Volume and Issue: 580(7803), P. 329 - 338

Published: April 15, 2020

Language: Английский

PROTAC targeted protein degraders: the past is prologue DOI Open Access
Miklós Békés, David R. Langley, Craig M. Crews

et al.

Nature Reviews Drug Discovery, Journal Year: 2022, Volume and Issue: 21(3), P. 181 - 200

Published: Jan. 18, 2022

Language: Английский

Citations

1902

RNA in cancer DOI
Gregory J. Goodall, Vihandha O. Wickramasinghe

Nature reviews. Cancer, Journal Year: 2020, Volume and Issue: 21(1), P. 22 - 36

Published: Oct. 20, 2020

Language: Английский

Citations

845

Targeted protein degradation: expanding the toolbox DOI
Matthieu Schapira, Matthew F. Calabrese, Alex N. Bullock

et al.

Nature Reviews Drug Discovery, Journal Year: 2019, Volume and Issue: 18(12), P. 949 - 963

Published: Oct. 30, 2019

Language: Английский

Citations

724

Roles and mechanisms of alternative splicing in cancer — implications for care DOI
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel

et al.

Nature Reviews Clinical Oncology, Journal Year: 2020, Volume and Issue: 17(8), P. 457 - 474

Published: April 17, 2020

Language: Английский

Citations

571

Ubiquitylation at the crossroads of development and disease DOI
Michael Rapé

Nature Reviews Molecular Cell Biology, Journal Year: 2017, Volume and Issue: 19(1), P. 59 - 70

Published: Sept. 20, 2017

Language: Английский

Citations

519

Advancing targeted protein degradation for cancer therapy DOI
Brandon Dale, Meng Cheng, Kwang‐Su Park

et al.

Nature reviews. Cancer, Journal Year: 2021, Volume and Issue: 21(10), P. 638 - 654

Published: June 15, 2021

Language: Английский

Citations

446

A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader DOI Creative Commons
Hai‐Tsang Huang,

Dennis Dobrovolsky,

Joshiawa Paulk

et al.

Cell chemical biology, Journal Year: 2017, Volume and Issue: 25(1), P. 88 - 99.e6

Published: Nov. 9, 2017

Language: Английский

Citations

392

Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16 DOI
Xiaoyu Zhang, Vincent M. Crowley, Thomas Wucherpfennig

et al.

Nature Chemical Biology, Journal Year: 2019, Volume and Issue: 15(7), P. 737 - 746

Published: June 17, 2019

Language: Английский

Citations

391

Development of targeted protein degradation therapeutics DOI
Philip P. Chamberlain, Lawrence G. Hamann

Nature Chemical Biology, Journal Year: 2019, Volume and Issue: 15(10), P. 937 - 944

Published: Sept. 16, 2019

Language: Английский

Citations

389

PROTACs: An Emerging Therapeutic Modality in Precision Medicine DOI Creative Commons

Dhanusha A. Nalawansha,

Craig M. Crews

Cell chemical biology, Journal Year: 2020, Volume and Issue: 27(8), P. 998 - 1014

Published: Aug. 1, 2020

Language: Английский

Citations

341